Misplaced Pages

Nebivolol/valsartan, sold under the brand name Byvalson among others, is a medication used to treat hypertension.

It is available as a generic medication.

References

1. ^ "Byvalson (nebivolol and valsartan) tablets, for oral use Initial U.S. Approval: 2016". DailyMed. Archived from the original on 24 September 2022. Retrieved 23 September 2022.
2. Lamberton NH, Copenhaver AM (January 2018). "Nebivolol/Valsartan (Byvalson) for Hypertension". American Family Physician. 97 (2): 124–125. PMID 29365224. Archived from the original on 24 September 2022. Retrieved 24 September 2022.
3. "2022 First Generic Drug Approvals". U.S. Food and Drug Administration (FDA). 3 March 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.

Further reading

• Ishak J, Rael M, Punzi H, Gradman A, Anderson LM, Patel M, et al. (January 2018). "Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension". Journal of Clinical Hypertension. 20 (1): 143–149. doi:10.1111/jch.13132. PMC 5813198. PMID 29105958.

External links

• "Nebivolol hydrochloride mixture with valsartan". Drug Information Portal. U.S. National Library of Medicine.

• Medicine

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Combination antihypertensive drugs
• Angiotensin II receptor antagonists
• Pharmacology stubs